This pathway may be correlated with PD-1 manipulation of STAT3 expression in patients with sarcoidosis since a recent study showed that PD- 1 inhibits PI3K expression in CD4+ T cells in sarcoidosis (60). Here, RPL17 is linked to sarcoidosis.